Transient enhanced IL-2R signaling early during priming rapidly amplifies development of functional CD8+ T effector-memory cells

Journal of Immunology

Volumn 189, Issue 9, 2012, Pages 4321-4330

  Castro, Iris ^a   Dee, Michael J ^a   Malek, Thomas R ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 2 IC; INTERLEUKIN 2 RECEPTOR; LIPOPOLYSACCHARIDE; OVALBUMIN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; CD8+ T EFFECTOR MEMORY CELL; CD8+ T LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; IMMUNE RESPONSE; IMMUNIZATION; LISTERIOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; ENHANCER ELEMENTS, GENETIC; GENE AMPLIFICATION; IMMUNIZATION, SECONDARY; IMMUNOLOGIC MEMORY; INFLAMMATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, INTERLEUKIN-2; SIGNAL TRANSDUCTION;

EID: 84867902958     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202067     Document Type: Article

References (56)

1. +) T cells: foot soldiers of the immune system. Immunity 35: 161-168.
2. Sallusto, F., A. Lanzavecchia, K. Araki, and R. Ahmed. 2010. From vaccines to memory and back. Immunity 33: 451-463.
3. + T cell differentiation during viral infection. Immunity 27: 393-405.
4. + T cell precursor can develop into diverse effector and memory subsets. Immunity 27: 985-997.
5. Chang, J. T., V. R. Palanivel, I. Kinjyo, F. Schambach, A. M. Intlekofer, A. Banerjee, S. A. Longworth, K. E. Vinup, P. Mrass, J. Oliaro, et al. 2007. Asymmetric T lymphocyte division in the initiation of adaptive immune responses. Science 315: 1687-1691. (Pubitemid 46515618)
6. Gerlach, C., J. W. van Heijst, E. Swart, D. Sie, N. Armstrong, R. M. Kerkhoven, D. Zehn, M. J. Bevan, K. Schepers, and T. N. Schumacher. 2010. One naive T cell, multiple fates in CD8+ T cell differentiation. J. Exp. Med. 207: 1235-1246.
7. + T central-memory cell survival but not T effector-memory cell development. J. Immunol. 187: 5170-5182.
8. Kalia, V., S. Sarkar, S. Subramaniam, W. N. Haining, K. A. Smith, and R. Ahmed. 2010. Prolonged interleukin-2Ralpha expression on virus-specific CD8+ T cells favors terminal-effector differentiation in vivo. Immunity 32: 91-103.
9. Malek, T. R., and I. Castro. 2010. Interleukin-2 receptor signaling: at the interface between tolerance and immunity. Immunity 33: 153-165.
10. Blattman, J. N., J. M. Grayson, E. J. Wherry, S. M. Kaech, K. A. Smith, and R. Ahmed. 2003. Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo. Nat. Med. 9: 540-547. (Pubitemid 36597099)
11. + T cells and NK cells driven by complexes of IL-2 and anti-IL-2 monoclonal antibody as novel approach of cancer immunotherapy. J. Immunol. 183: 4904-4912.
12. Chang, J., S. Y. Choi, H. T. Jin, Y. C. Sung, and T. J. Braciale. 2004. Improved effector activity and memory CD8 T cell development by IL-2 expression during experimental respiratory syncytial virus infection. J. Immunol. 172: 503-508. (Pubitemid 38020506)
13. + T cells increases the size of the acute antiviral response and of the resulting memory T cell pool. J. Immunol. 169: 4990-4997.
14. Boyman, O., M. Kovar, M. P. Rubinstein, C. D. Surh, and J. Sprent. 2006. Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Science 311: 1924-1927.
15. Létourneau, S., E. M. van Leeuwen, C. Krieg, C. Martin, G. Pantaleo, J. Sprent, C. D. Surh, and O. Boyman. 2010. IL-2/anti-IL-2 antibody complexes show strong biological activity by avoiding interaction with IL-2 receptor alpha subunit CD25. Proc. Natl. Acad. Sci. USA 107: 2171-2176.
16. Hamilton, S. E., J. M. Schenkel, A. D. Akue, and S. C. Jameson. 2010. IL-2 complex treatment can protect naive mice from bacterial and viral infection. J. Immunol. 185: 6584-6590.
17. + T cells differentiate into protective memory-like cells after IL-2 anti IL-2 complex treatment in vivo. J. Exp. Med. 204: 1803-1812.
18. Tang, Q., J. Y. Adams, C. Penaranda, K. Melli, E. Piaggio, E. Sgouroudis, C. A. Piccirillo, B. L. Salomon, and J. A. Bluestone. 2008. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 28: 687-697.
19. Webster, K. E., S. Walters, R. E. Kohler, T. Mrkvan, O. Boyman, C. D. Surh, S. T. Grey, and J. Sprent. 2009. In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression. J. Exp. Med. 206: 751-760.
20. + T cell contraction is controlled by early inflammation. Nat. Immunol. 5: 809-817.
21. Blair, D. A., D. L. Turner, T. O. Bose, Q. M. Pham, K. R. Bouchard, K. J. Williams, J. P. McAleer, L. S. Cauley, A. T. Vella, and L. Lefrançois. 2011. Duration of antigen availability influences the expansion and memory differentiation of T cells. J. Immunol. 187: 2310-2321.
22. Prlic, M., G. Hernandez-Hoyos, and M. J. Bevan. 2006. Duration of the initial TCR stimulus controls the magnitude but not functionality of the CD8+ T cell response. J. Exp. Med. 203: 2135-2143. (Pubitemid 44352234)
23. Carrio, R., O. F. Bathe, and T. R. Malek. 2004. Initial antigen encounter programs CD8+ T cells competent to develop into memory cells that are activated in an antigen-free, IL-7- and IL-15-rich environment. J. Immunol. 172: 7315-7323. (Pubitemid 38747591)
24. + T cell differentiation. J. Immunol. 187: 4967-4978.
25. Joshi, N. S., and S. M. Kaech. 2008. Effector CD8 T cell development: a balancing act between memory cell potential and terminal differentiation. J. Immunol. 180: 1309-1315.
26. + effector and memory T cells. J. Immunol. 184: 6719-6730.
27. + T cells in primary and secondary responses. Proc. Natl. Acad. Sci. USA 107: 193-198.
28. + memory T cells. Nature 441: 890-893.
29. Pipkin, M. E., J. A. Sacks, F. Cruz-Guilloty, M. G. Lichtenheld, M. J. Bevan, and A. Rao. 2010. Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells. Immunity 32: 79-90.
30. Suzuki, H., T. M. Kündig, C. Furlonger, A. Wakeham, E. Timms, T. Matsuyama, R. Schmits, J. J. L. Simard, P. S. Ohashi, H. Griesser, et al. 1995. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor β. Science 268: 1472-1476.
31. + T regulatory cells. J. Immunol. 178: 4062-4071.
32. Foulds, K. E., L. A. Zenewicz, D. J. Shedlock, J. Jiang, A. E. Troy, and H. Shen. 2002. Cutting edge: CD4 and CD8 T cells are intrinsically different in their proliferative responses. J. Immunol. 168: 1528-1532. (Pubitemid 34135743)
33. + T cells. J. Immunol. 155: 1873-1883.
34. Malek, T. R., and J. D. Ashwell. 1985. Interleukin 2 upregulates expression of its receptor on a T cell clone. J. Exp. Med. 161: 1575-1580. (Pubitemid 15046049)
35. Nelson, B. H., and D. M. Willerford. 1998. Biology of the interleukin-2 receptor. Adv. Immunol. 70: 1-81. (Pubitemid 128678836)
36. Waldmann, T. A. 2006. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat. Rev. Immunol. 6: 595-601. (Pubitemid 44134092)
37. Surh, C. D., O. Boyman, J. F. Purton, and J. Sprent. 2006. Homeostasis of memory T cells. Immunol. Rev. 211: 154-163. (Pubitemid 43882969)
38. + T cell fate coupled by T-bet and eomesodermin. Nat. Immunol. 6: 1236-1244.
39. + T cells. Nat. Immunol. 12: 1230-1237.
40. + T cell subsets. Nat. Immunol. 12: 1221-1229.
41. +) T cells depend on T cell factor 1. Immunity 33: 229-240.
42. Jenkins, M. K., H. H. Chu, J. B. McLachlan, and J. J. Moon. 2010. On the composition of the preimmune repertoire of T cells specific for peptide-major histocompatibility complex ligands. Annu. Rev. Immunol. 28: 275-294.
43. Pamer, E. G. 2004. Immune responses to Listeria monocytogenes. Nat. Rev. Immunol. 4: 812-823. (Pubitemid 39336297)
44. +) T cell fates via the graded expression of T-bet transcription factor. Immunity 27: 281-295.
45. Nguyen, C. L., M. L. Salem, M. P. Rubinstein, M. Demcheva, J. N. Vournakis, D. J. Cole, andW. E. Gillanders. 2003. Mechanisms of enhanced antigen-specific T cell response following vaccination with a novel peptide-based cancer vaccine and systemic interleukin-2 (IL-2). Vaccine 21: 2318-2328. (Pubitemid 36561323)
46. Araki, K., A. P. Turner, V. O. Shaffer, S. Gangappa, S. A. Keller, M. F. Bachmann, C. P. Larsen, and R. Ahmed. 2009. mTOR regulates memory CD8 T-cell differentiation. Nature 460: 108-112.
47. Kim, E. H., J. A. Sullivan, E. H. Plisch, M. M. Tejera, A. Jatzek, K. Y. Choi, and M. Suresh. 2012. Signal integration by Akt regulates CD8 T cell effector and memory differentiation. J. Immunol. 188: 4305-4314.
48. Pearce, E. L., M. C. Walsh, P. J. Cejas, G. M. Harms, H. Shen, L. S. Wang, R. G. Jones, and Y. Choi. 2009. Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature 460: 103-107.
49. + T cell memory development. Immunity 36: 68-78.
50. + T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature 421: 852-856.
51. Shedlock, D. J., and H. Shen. 2003. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 300: 337-339. (Pubitemid 36433726)
52. Sun, J. C., and M. J. Bevan. 2003. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 300: 339-342. (Pubitemid 36433727)
53. + T cells in immunity to viruses. Nat. Rev. Immunol. 12: 136-148.
54. Croft, M. 2010. Control of immunity by the TNFR-related molecule OX40 (CD134). Annu. Rev. Immunol. 28: 57-78.
55. Wang, C., G. H. Lin, A. J. McPherson, and T. H.Watts. 2009. Immune regulation by 4-1BB and 4-1BBL: complexities and challenges. Immunol. Rev. 229: 192-215.
56. + T cell help. J. Immunol. 180: 4382-4390.